These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37379738)

  • 1. Serum proteomics analysis for differentiation among Mycobacterium tuberculosis infection categories.
    Kaewseekhao B; Sirichoat A; Roytrakul S; Yingchutrakul Y; Reechaipichitkul W; Faksri K
    Tuberculosis (Edinb); 2023 Jul; 141():102366. PubMed ID: 37379738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis.
    Kaewseekhao B; Roytrakul S; Yingchutrakul Y; Salao K; Reechaipichitkul W; Faksri K
    PLoS One; 2020; 15(4):e0231834. PubMed ID: 32298370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and surface-enhanced Raman spectroscopy.
    Kaewseekhao B; Nuntawong N; Eiamchai P; Roytrakul S; Reechaipichitkul W; Faksri K
    Tuberculosis (Edinb); 2020 Mar; 121():101916. PubMed ID: 32279876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
    Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
    Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
    Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
    Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
    Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
    Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
    Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
    Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations.
    Luo D; Shi CY; Wei NS; Yang BY; Qin K; Liu G; Dong BQ; Qin YX; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Li H; Li J
    Tuberculosis (Edinb); 2023 Dec; 143():102413. PubMed ID: 37832478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
    Wayengera M; Kateete DP; Asiimwe B; Joloba ML
    BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of plasma proteins in children of different
    Li J; Sun L; Xu F; Xiao J; Jiao W; Qi H; Shen C; Shen A
    Oncotarget; 2017 Nov; 8(61):103290-103301. PubMed ID: 29262562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New genetic biomarkers from transcriptome RNA-sequencing for Mycobacterium tuberculosis complex and Mycobacterium avium complex infections by bioinformatics analysis.
    Jia Q; Wu Y; Huang Y; Bai X
    Sci Rep; 2024 Jul; 14(1):17385. PubMed ID: 39075154
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Osugi A; Tamaru A; Yoshiyama T; Iwamoto T; Mitarai S; Murase Y
    Microbiol Spectr; 2024 Jul; 12(7):e0428923. PubMed ID: 38786200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
    Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
    [No Abstract]   [Full Text] [Related]  

  • 20. A Systematic Review on Novel
    Meier NR; Jacobsen M; Ottenhoff THM; Ritz N
    Front Immunol; 2018; 9():2476. PubMed ID: 30473692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.